Roseola pathophysiology

Jump to navigation Jump to search

Roseola Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Roseola from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Roseola pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Roseola pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Roseola pathophysiology

CDC on Roseola pathophysiology

Roseola pathophysiology in the news

Blogs on Roseola pathophysiology

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Roseola pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Primary infection with HHV-6 has been shown to be the cause of exanthem subitum (roseola) in infants and can also result in an infectious mononucleosis-like illness in adults.

Pathophysiology

Classical roseola has two phases:

  1. The febrile phase
  2. The rash phase

Transmission of infection

The febrile phase

  • HHV 6 virus is replicated in the salivary glands and secreted in saliva in the primary infection.
  • Intrauterine transmission was suggested by polymerase chain reaction (PCR) positivity of uncultured cord blood mononuclear cells.
  • CNS invasion is believed to occur in rare cases accounting for some of the CNS manifestations such as febrile seizures.

The rash phase

  • In the second phase of the disease, the HHV 6 virus is found to remain latent in lymphocytes and monocytes and found in low levels in some tissues. CD4 positive T cells have been found to support the growth of roseola.

Pathogenesis

  • The pathogenesis of roseola is unknown. However, in a prospective study of 38 children with roseola, human herpesvirus 6 (HHV-6) was detected in a blood sample in all of the children during the period of high fever [1].
  • The human herpes virus infects the T cells, monocytes-macrophages, epithelial cells, and central nervous system cells resulting in a chronic infection.
  • HHV-6 has tropism towards CD4 T cells and replicates in the T cells inducing a lifelong latent infection in humans.
  • The pathogenicity of HHV-7 is not well understood.

Genetics

  • Chromosomal integration of HHV-6A and HHV-6B is responsible for transmission of infection from the parents to the newborn and is observed in 1% of the population.

Associated conditions

A more serious form of HHV 6 is seen in older children, imnmunocompromised adults and organ transplant patients.

Gross pathology

There are no gross pathologic findings associated with roseola.

Microscopic pathology

There are no microscopic findings associated with roseola.

References

  1. Asano Y, Yoshikawa T, Suga S, Yazaki T, Hata T, Nagai T; et al. (1989). "Viremia and neutralizing antibody response in infants with exanthem subitum". J Pediatr. 114 (4 Pt 1): 535–9. PMID 2647944.